Case Study: To Cure a Rose advances rare disease ASO therapy discovery with bit.bio's human neurons

A bit.bio Case Study

Preview of the To Cure A Rose Case Study

To Cure A Rose identifies 2 lead ASOs with bit.bio's ioGABAergic Neurons

The non-profit organization To Cure a Rose, founded to accelerate research for an ultra-rare neurodevelopmental disorder, faced significant challenges in modeling the disease. Patient-derived cells were difficult to culture and differentiate into neurons, and conventional methods were slow and inconsistent. They urgently needed a consistent, defined source of human neurons with readily available gene expression data to identify cells expressing their target protein.

bit.bio provided its ioGABAergic Neurons, powered by opti-ox technology, which offered the required consistency and scalability along with comprehensive gene expression data. This allowed the team to immediately confirm the cells were the right fit. With support from bit.bio, they screened 57 ASOs and identified two lead candidates with strong activity and no toxicity. This progress has accelerated their work, enabling them to advance the candidates into toxicology studies ahead of a planned clinical trial.


View this case study…

bit.bio

6 Case Studies